Provided by Tiger Trade Technology Pte. Ltd.

Abivax S.A.

102.23
-4.4300-4.15%
Post-market: 102.500.2700+0.26%19:48 EDT
Volume:1.89M
Turnover:196.81M
Market Cap:8.90B
PE:-19.60
High:107.16
Open:106.38
Low:101.29
Close:106.66
52wk High:148.83
52wk Low:69.81
Shares:87.05M
Float Shares:76.46M
Volume Ratio:1.50
T/O Rate:2.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.2168
EPS(LYR):-5.6758
ROE:-157.07%
ROA:-44.65%
PB:18.07
PE(LYR):-18.01

Loading ...

Abivax Sa : Jefferies Raises Target Price to $108 From $90

THOMSON REUTERS
·
Jun 22

U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon

Reuters
·
Jun 22

Movement Alert|Abivax S.A. Rises 5.15% in Regular Trading, Technical Rebound Continues as Phase 3 Safety Concerns Are Digested

Market Focus
·
Jun 17

Abivax SA Sponsored ADR (ABVX) Gets a Buy from Guggenheim

TIPRANKS
·
Jun 16

Analysts Are Bullish on These Healthcare Stocks: Encompass Health (EHC), Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Jun 16

Barclays Keeps Their Buy Rating on Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Jun 16

Movement Alert|Abivax S.A. Rises 5.03% in Regular Trading, Technical Rebound Continues as Phase 3 Safety Concerns Digested

Market Focus
·
Jun 16

Movement Alert|Abivax S.A. Falls 5.27% in Regular Trading, Phase 3 Trial Cancer Safety Concerns Compounded by Securities Fraud Investigation

Market Focus
·
Jun 10

Movement Alert|Abivax S.A. Falls 5.32% in Regular Trading, Phase 3 Trial Cancer Safety Concerns Continue to Weigh on Stock

Market Focus
·
Jun 08

Analysts Offer Insights on Healthcare Companies: Phibro Animal Health (PAHC) and Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Jun 07

Movement Alert|Abivax S.A. Falls 5.49% in Regular Trading, Phase 3 Trial Cancer Case Safety Concerns Continue to Weigh on Shares

Market Focus
·
Jun 05

Movement Alert|Abivax S.A. Rises 5.65% in Regular Trading, Extending Rebound After Phase 3 Trial Cancer Scare Triggered 40%+ Selloff

Market Focus
·
Jun 04

This Is Why Abivax Stock (ABVX) Is Up Today

TIPRANKS
·
Jun 04

Abivax price target lowered to $136 from $176 at Wolfe Research

TIPRANKS
·
Jun 04

Abivax rises 14.1%

TIPRANKS
·
Jun 03

Movement Alert|Abivax S.A. Rises 16.03% in Regular Trading, Partial Rebound After Phase 3 Trial Cancer Cases Triggered 40% Plunge

Market Focus
·
Jun 03

Movement Alert|Abivax S.A. Rises 6.21% in Pre-Market Trading, Partial Rebound After Phase 3 Trial Cancer Concerns Triggered 40% Crash

Market Focus
·
Jun 03

Analysts Have Conflicting Sentiments on These Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Bausch Health Companies (BHC) and Healthequity (HQY)

TIPRANKS
·
Jun 03

Movement Alert|Abivax S.A. Rises 5.28% Overnight, Partial Rebound After 40% Crash on Phase 3 Trial Cancer Safety Concerns

Market Focus
·
Jun 03

Movement Alert|Abivax S.A. Rises 5.12% in After-Hours Trading, Modest Rebound Following 40% Intraday Plunge on Phase 3 Cancer Safety Concerns

Market Focus
·
Jun 03